News
- News
- Language
- Product
- GORE® BIO-A® Tissue Reinforcement (3)
- GORE® DUALMESH® Biomaterial (1)
- GORE® DUALMESH® PLUS Biomaterial (1)
- GORE® Embolic Filter (2)
- GORE® EXCLUDER® AAA Endoprosthesis (16)
- GORE® Flow Reversal System (3)
- GORE® HELEX Septal Occluder (12)
- GORE® INFINIT Mesh (1)
- GORE® PRECLUDE® Vessel Guard (2)
- GORE® PROPATEN® Vascular Graft (5)
- GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement (1)
- GORE® TAG® Thoracic Endoprosthesis (12)
- GORE® VIABAHN® Endoprosthesis (24)
- GORE® VIABIL® Biliary Endoprosthesis (2)
- GORE® VIATORR® TIPS Endoprosthesis (2)
- GORE-TEX® Stretch Vascular Graft For Vascular Access (1)
- GORE-TEX® Vascular Graft (2)
- GORE® 3D Imaging System (2)
- GORE® ACUSEAL Vascular Graft (1)
- GORE® BIO-A® Fistula Plug (1)
- GORE® DrySeal Sheath (3)
- GORE® HELEX Septal Occluder (11)
- GORE® Hybrid Vascular Graft (4)
- GORE® Septal Occluder (3)
- GORE® TAG® Thoracic Endoprosthesis (12)
- GORE® TAG® Thoracic Endoprosthesis (19)
- GORE® VIABAHN® Endoprosthesis (18)
- GORE® VIABAHN® Endoprothesis (19)
Gore receives FDA approval for GORE VIABAHN® Endoprosthesis with Heparin Bioactive Surface
05 September 2007 - Heparin-Bonded Endoprosthesis for Superficial Femoral Artery Interventions
05 September 2007 - Heparin-Bonded Endoprosthesis for Superficial Femoral Artery Interventions
Gore receives FDA approval for GORE VIABAHN® Endoprosthesis with Heparin Bioactive Surface
05 September 2007 - Heparin-Bonded Endoprosthesis for Superficial Femoral Artery Interventions
05 September 2007 - Heparin-Bonded Endoprosthesis for Superficial Femoral Artery Interventions
W. L. Gore & Associates Announces Land Purchase in Phoenix Area
02 August 2007 - W. L. Gore & Associates (Gore) announced that it will expand its Medical Products Division's operations in Arizona after completing the purchase today of approximately 40 acres of land in North Phoenix.
02 August 2007 - W. L. Gore & Associates (Gore) announced that it will expand its Medical Products Division's operations in Arizona after completing the purchase today of approximately 40 acres of land in North Phoenix.
Gore REVISE Study Receives Conditional Approval From FDA
12 July 2007 - Conditional approval to proceed with the Gore REVISE (VasculaR AccEss ReVision with GORE VIABAHN® EndoproSthesis vs PercutanEous Transluminal Angioplasty) Study was announced today by W. L. Gore & Associates.
12 July 2007 - Conditional approval to proceed with the Gore REVISE (VasculaR AccEss ReVision with GORE VIABAHN® EndoproSthesis vs PercutanEous Transluminal Angioplasty) Study was announced today by W. L. Gore & Associates.
Gore REVISE Study Receives Conditional Approval From FDA
12 July 2007 - Conditional approval to proceed with the Gore REVISE (VasculaR AccEss ReVision with GORE VIABAHN® EndoproSthesis vs PercutanEous Transluminal Angioplasty) Study was announced today by W. L. Gore & Associates.
12 July 2007 - Conditional approval to proceed with the Gore REVISE (VasculaR AccEss ReVision with GORE VIABAHN® EndoproSthesis vs PercutanEous Transluminal Angioplasty) Study was announced today by W. L. Gore & Associates.
Gore REVISE Study Receives Conditional Approval From FDA
12 July 2007 - Conditional approval to proceed with the Gore REVISE (VasculaR AccEss ReVision with GORE VIABAHN® EndoproSthesis vs PercutanEous Transluminal Angioplasty) Study was announced today by W. L. Gore & Associates.
12 July 2007 - Conditional approval to proceed with the Gore REVISE (VasculaR AccEss ReVision with GORE VIABAHN® EndoproSthesis vs PercutanEous Transluminal Angioplasty) Study was announced today by W. L. Gore & Associates.
Patient Enrollment Begins in Study on Efficacy of GORE SEAMGUARD® Staple Line Reinforcement for Circular Surgical Staplers
21 May 2007 - More than 2,500 colorectal implants of GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement for circular surgical staplers in past year
21 May 2007 - More than 2,500 colorectal implants of GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement for circular surgical staplers in past year
GORE PRECLUDE® Vessel Guard Reduces Vascular Injury Risk Following Anterior Vertebral Surgery
07 May 2007 - W. L. Gore & Associates (Gore) announced today the availability of GORE PRECLUDE® Vessel Guard, the first non-biological membrane indicated as a cover for vessels following anterior vertebral surgery.
07 May 2007 - W. L. Gore & Associates (Gore) announced today the availability of GORE PRECLUDE® Vessel Guard, the first non-biological membrane indicated as a cover for vessels following anterior vertebral surgery.
W. L. Gore & Associates Announces Expansions in Arizona
21 February 2007 - W. L. Gore & Associates, Inc announced today expansion plans for its Arizona medical products operations to meet anticipated growth.
21 February 2007 - W. L. Gore & Associates, Inc announced today expansion plans for its Arizona medical products operations to meet anticipated growth.
W. L. Gore & Associates enrolls first patient in study of 45 mm GORE TAG® Thoracic Endoprosthesis
20 February 2007 - W. L. Gore & Associates announced today that the first patient has been enrolled in a US Food and Drug Administration (FDA) approved IDE study for the 45 mm* GORE TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta.
20 February 2007 - W. L. Gore & Associates announced today that the first patient has been enrolled in a US Food and Drug Administration (FDA) approved IDE study for the 45 mm* GORE TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta.
GORE DUALMESH® PLUS Biomaterial Inhibits Implant Infections by Drug-resistant 'superbugs® and Resists Biofilm Development
14 February 2007 - Hernia repair patch is the only to inhibit adherence of 10 different bacteria and resist initial biofilm formation for 14 days post-implantation
14 February 2007 - Hernia repair patch is the only to inhibit adherence of 10 different bacteria and resist initial biofilm formation for 14 days post-implantation
W. L. Gore & Associates marks 10th year as one of nation's best
08 January 2007 - W. L. Gore & Associates, Inc., maker of GORE-TEX® fabric and thousands of other innovative products, today announced it has earned a position on FORTUNE magazine's annual list of the ®100 Best Companies to Work For® for the 10th consecutive year.
08 January 2007 - W. L. Gore & Associates, Inc., maker of GORE-TEX® fabric and thousands of other innovative products, today announced it has earned a position on FORTUNE magazine's annual list of the ®100 Best Companies to Work For® for the 10th consecutive year.
Gore CEO Terri Kelly in Fast Company Feature
24 January 2005 - The September 2005 issue of Fast Company magazine turns the spotlight on Terri Kelly, the president and CEO of W. L. Gore & Associates.
24 January 2005 - The September 2005 issue of Fast Company magazine turns the spotlight on Terri Kelly, the president and CEO of W. L. Gore & Associates.
Trauma Indication Press ReleaseConformable GORE® TAG® Thoracic Endoprosthesis
(205 KB, 1 pages, .pdf)
Features and BenefitsEXCLUDER® AAA Endoprosthesis 31 mm US Product Availability
(91 KB, 1 pages, .pdf)
First Patient Treated with 25cm Longest LengthGORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface
(106 KB, 1 pages, .pdf)
NewsVIABAHN® Endoprosthesis with Heparin Bioactive Surface Large Diameter Press Release
(92 KB, 1 pages, .pdf)
25cm Longest Length CE Mark Approval Press ReleaseGORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface
(138 KB, 1 pages, .pdf)
VIPER Study Completes Enrollment Press ReleaseGORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface
(106 KB, 1 pages, .pdf)
First Patient GORE® ACUSEAL Vascular Graft Clinical Study Press ReleaseGORE® ACUSEAL Vascular Graft
(122 KB, 1 pages, .pdf)
NewsEXCLUDER® AAA Endoprosthesis Q50 Stent Graft Balloon Catheter Press Release
(115 KB, 2 pages, .pdf)